-
Clinical Trial Planned to Test Therapy C76 to Potentially Reverse PAH
Read about a new clinical trial, being planned to begin in 2019, to test a therapy, C76, to potentially reverse pulmonary arterial hypertension.
Click here to find out more about this study about a potential therapy to reverse PAH: Clinical Trial Expected in 2019 to Test Therapy C76 as Potential PAH Inhibitor
What are your thoughts on this news?
Log in to reply.